EPISODE · May 12, 2026 · 7 MIN
SHTG Digest — Tuesday May 12, 2026
from SHTG Daily Digest — Weiss Lab
A thin top-tier journal week pushed Part A to the next-best tier, where ApoC-III inhibitors keep stacking up favorable meta-analytic evidence and a new HNF4A–SPP2–LPL axis hints at fresh small-molecule entry points; the industry side is also quiet — the dominant story over the past seven days remains the run-up to the late-June Tryngolza sHTG PDUFA, with no major company-specific lipid news from the allowed outlets.
Embed this episode
NOW PLAYING
SHTG Digest — Tuesday May 12, 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.